Success Metrics

Completion Rate
0%(0/2)
Active Trials
0(0%)
Terminated
2(67%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(2)
Other(1)

Detailed Status

Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
0.0%

Trials by Status

terminated267%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
terminated

Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases

NCT04119115
terminated

Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2

NCT04320511
unknown

CTV Exploration of 3D-PT Assisted CT-guided I-125 Seeds Implantation for Recurrent Rectal Cancer

NCT04710589

Clinical Trials (3)

Showing 3 of 3 trials
NCT04119115

Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases

Terminated
NCT04320511

Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2

Terminated
NCT04710589

CTV Exploration of 3D-PT Assisted CT-guided I-125 Seeds Implantation for Recurrent Rectal Cancer

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3